oxotremorine has been researched along with Cognition Disorders in 3 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Overk, CR | 1 |
| Felder, CC | 1 |
| Tu, Y | 1 |
| Schober, DA | 1 |
| Bales, KR | 1 |
| Wuu, J | 1 |
| Mufson, EJ | 1 |
| Ichikawa, J | 1 |
| Chung, YC | 1 |
| Li, Z | 1 |
| Dai, J | 1 |
| Meltzer, HY | 1 |
| Gordon, I | 1 |
| Grauer, E | 1 |
| Genis, I | 1 |
| Sehayek, E | 1 |
| Michaelson, DM | 1 |
3 other studies available for oxotremorine and Cognition Disorders
| Article | Year |
|---|---|
Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.
Topics: Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Binding, Competitive; Biomarkers; Cerebra | 2010 |
Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Topics: Acetylcholine; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Cognition Disorders; Dopamine; Ma | 2002 |
Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Autonomic Nervous System Diseases; Brain; Choline O-Acetyltransferase; C | 1995 |